Evaluating the efficacy of upadacitinib in patients with moderate rheumatoid arthritis: a post-hoc analysis of the SELECT phase 3 trials.
Philip Gerard ConaghanKarel PavelkaSong-Chou HsiehTerri-Leigh BonningtonToby C KentKatie MarchbankChristopher J EdwardsPublished in: Rheumatology advances in practice (2023)
ClinicalTrials.gov: SELECT-NEXT: NCT02675426; SELECT-COMPARE: NCT02629159; SELECT-MONOTHERAPY: NCT02706951; SELECT-BEYOND: NCT02706847.